Navigation Links
Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
Date:7/30/2008

LONDON, July 30 /PRNewswire/ -- Silence Therapeutics plc (AIM: SLN), a leading European RNAi focused biotechnology company, today announces that its partner, Quark Pharmaceuticals Inc. ("Quark") together with Pfizer, has commenced a Phase II clinical trial with RTP-801i-14 (PF-4523655), a small interfering RNA (siRNA) therapeutic product based on Silence's AtuRNAi technology. Its initiation triggers a $1.9 million milestone payment to Silence from Quark.

The study is designed to evaluate the effectiveness of the candidate in improving visual acuity compared to laser treatment in patients with diabetic macular oedema. The Phase II study is being funded and is conducted by Pfizer Inc. in collaboration with Quark. Pfizer in-licensed RTP-801i-14 from Quark in a deal announced in 2006 for the treatment of age-related macular degeneration (AMD) and other ophthalmologic and non-ophthalmologic indications.

Diabetic macular oedema results in the macula swelling and surrounding blood vessels dilating to compensate for this. The dilated vessels are generally leaky, resulting in fluid build-up in the macula, which in turn causes the macula to swell and cease to function. Diabetic macular oedema is the most common cause of visual impairment in patients with non-proliferative retinopathy. Approximately 14% of people with diabetes have diabetic macular oedema with prevalence increasing to 29% for people with diabetes who use insulin for more than 20 years.

In December 2004 Quark and Silence Therapeutics AG signed a Collaboration Agreement on the development of siRNA molecules for the gene target RTP-801, which resulted in RTP801i-14, a 19 base pairs long blunt-ended AtuRNAi (siRNA) molecule and also provided Quark with a license to AtuRNAi technology. In addition a second agreement (Option and License Agreement) was signed in April 2005, and expanded in 2007, to provide Quark with options for non-exclusive licenses to develop additional molecules agains
'/>"/>

SOURCE Silence Therapeutics plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Actress and New Mom Keri Russell Joins PKIDs to launch Silence the Sounds of Pertussis Campaign
2. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
3. Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach
4. Silence Therapeutics Announces Board Changes
5. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
6. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
7. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
8. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
9. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
10. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
11. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... 2015 According to a ... Rhythm Management Market ECG, Implantable Loop Recorder, Manual ... Defibrillator, Dual Chamber Pacemaker, CRT-D, CRT-P - Global ... Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) ... by 2020 from $21,137.7 Million in 2015, at ...
(Date:7/3/2015)... -- Redwood Pharma AB has entered into ... in both the US and China ... supramolecular hydrogel technology in its lead chronic Dry Eye ... Broda technology offers many unique competitive benefits. At lower ... with low concentrations of polymer the system can be ...
(Date:7/2/2015)... ResMed Inc. (NYSE: RMD ) today announced that it ... 30, 2015 results on Thursday, July 30, 2015, after the ... ResMed,s results will be issued after 1:00 p.m. US Pacific ... operating results and future outlook. The earnings call ... and the live webcast of the call can be accessed ...
Breaking Medicine Technology:Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 2Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 3Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 4Redwood Pharma Licenses Novel Hydrogel Drug Delivery Technology From Broda Technologies 2ResMed to Announce Fourth Quarter and Fiscal Year-End 2015 Results 2
... 3, 2012  MultiCell Technologies, Inc. (OTC Bulletin Board: MCET.OB) ... $303,102 under the U.S. Government,s Qualifying Therapeutic Discovery Project ... as part of the Patient Protection and Affordable Care ... equal to eligible costs and expenses. ...
... 2012  Vivo Ventures, a healthcare investment firm with offices ... the final closing of Vivo Ventures VII ("Vivo VII") ... under management to more than $1 billion. ... later development stage pharmaceutical and medical device companies in ...
Cached Medicine Technology:MultiCell Technologies Receives Final Payment Under QTDP Program 2MultiCell Technologies Receives Final Payment Under QTDP Program 3Vivo Ventures Closes $375 Million 7th Fund to Invest in Healthcare in the U.S. and Greater China 2
(Date:7/3/2015)... St. Louis, MO (PRWEB) , ... July 03, 2015 , ... ... new responsive website to replace their existing Talcum Powder Cancer Lawsuit Center website. Just ... for talcum powder lawsuit news , offering timely lawsuit updates and ovarian cancer ...
(Date:7/3/2015)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, ... and expose popular lies regarding proper relationships according to the bible. , ... the core of the subject by explaining why certain types of sexual relationships are ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to announce ... sweetFrog store located in the Lone Star State. The premium frozen yogurt chain was listed ... store, which opened June 19 in the Village at Bachman Lake, is located at:, 3701 ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... ... the parking structure retrofit project at the University of Minnesota, they knew it ... that it would also be an award-winning choice: the total energy savings after ...
(Date:7/2/2015)... ... July 02, 2015 , ... “ LIFX ” was featured on NewsWatch as ... available to consumers. Amanda Forstrom, a technology expert and special reporter for NewsWatch, conducted ... smart light bulbs on the market. , According to the U.S. Department of Energy, ...
Breaking Medicine News(10 mins):Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:sweetFrog Opens 18th Location in the Lone Star State 2Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2Health News:The Most Versatile Smart Light Bulbs were featured on NewsWatch Television 2
... BURLINGAME, Calif., August 19 Urigen,Pharmaceuticals, Inc. ... a,specialty pharmaceutical company focused on the development ... announced,the U.S. Patent and Trademark Office has ... URG101, an investigational, bladder instillation treatment for,Painful ...
... Ariz., Aug. 19 Employee Vita, a Chandler,Arizona-based ... a new nutritional supplement targeted toward,nurses. The web-based ... to offer,supplements that address the health needs of ... from those in other occupations," said,Brett Waslefsky, president ...
... Cadient ... Group,s creative process, WEST CONSHOHOCKEN, ... agency serving the healthcare,industry, today announced the appointment of Andrew ... lead Cadient Group,s creative,team and will work with client-facing groups, ...
... Search, RARITAN, N.J., Aug. 19 The first ... identify real-life "It Girls" who embody,confidence and reliability was ... Millennial generation, the finalists proved that intelligence,reliability, talent and ... this much talked about group. The "It Girl Essentials" ...
... Voters Favor Stronger Coverage for Wheelchairs,Oxygen, and Other Home ... Nearly three out of,four (74 percent) American voters ... the problem of rapidly increasing Medicare spending for,America,s seniors." ... (81,percent)., A national telephone survey of 1,000 American ...
... Lisa Zdinak, oculoplastic surgeon and medical skin care specialist, is the ... non-surgical treatment for stretch-marks, cellulite reduction, dark under-eye circles, and non-surgical ... ... New York, NY (PRWeb) August 19, 2008 -- Dr. Lisa ...
Cached Medicine News:Health News:Urigen Announces Issuance of Key Patent for URG101 - A Novel Therapy to Treat Painful Bladder Syndrome/Interstitial Cystitis 2Health News:Urigen Announces Issuance of Key Patent for URG101 - A Novel Therapy to Treat Painful Bladder Syndrome/Interstitial Cystitis 3Health News:New Vitamin Targets Needs of Nurses 2Health News:Cadient Group Appoints Andrew le Blanc as Creative Director 2Health News:Reliability & Confidence Define a Nation Of 'It Girls' 2Health News:Reliability & Confidence Define a Nation Of 'It Girls' 3Health News:Reliability & Confidence Define a Nation Of 'It Girls' 4Health News:Reliability & Confidence Define a Nation Of 'It Girls' 5Health News:Republican and Democratic Voters View Home Care as a Solution to Rising Medicare Spending, Harris Survey Finds 2Health News:Republican and Democratic Voters View Home Care as a Solution to Rising Medicare Spending, Harris Survey Finds 3Health News:Dr. Lisa Zdinak Announces, CO2TouchTM Brazilian Carboxytherapy - New Technology for Non-Surgical Treatment of Stretch Marks, Cellulite and Dark Undereye Circles 2Health News:Dr. Lisa Zdinak Announces, CO2TouchTM Brazilian Carboxytherapy - New Technology for Non-Surgical Treatment of Stretch Marks, Cellulite and Dark Undereye Circles 3
... A lower cost alternative to Equalizers, the patented ... between two different vessel configurations. With the push ... be quickly and easily adjusted for test tubes ... Ergonomic Design for Unparalleled Comfort Pick one ...
... Exp Expandable Tip System A lower cost ... you to perform multi-sample transfers between two different ... a knob, tip spacing can be quickly and ... or 96 well plates. Ergonomic Design for ...
... Exp Expandable Tip System A ... System allows you to perform multi-sample transfers between ... pull of a knob, tip spacing can be ... microcentrifuge tubes) or 96 well plates. Ergonomic ...
... Expandable Tip System A lower cost alternative ... to perform multi-sample transfers between two different vessel ... knob, tip spacing can be quickly and easily ... 96 well plates. Ergonomic Design for Unparalleled ...
Medicine Products: